Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

Detalles Bibliográficos
Autores principales: Nakamura, Ikuo, Zakharia, Kais, Banini, Bubu A., Mikhail, Dalia S., Kim, Tae Hyo, Yang, Ju Dong, Moser, Catherine D., Shaleh, Hassan M., Thornburgh, Sarah R., Walters, Ian, Roberts, Lewis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631495/
https://www.ncbi.nlm.nih.gov/pubmed/26528545
http://dx.doi.org/10.1371/journal.pone.0142355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631495/
https://www.ncbi.nlm.nih.gov/pubmed/26528545
http://dx.doi.org/10.1371/journal.pone.0142355

Ejemplares similares